• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20088962).
  

PubMed=20088962; DOI=10.1111/j.1349-7006.2009.01462.x; PMCID=PMC11158935
Hidenori Ojima, Daitaro Yoshikawa, Yoshihiro Ino, Hiroko Shimizu, Masashi Miyamoto, Akiko Kokubu, Nobuyoshi Hiraoka, Noriaki Morofuji, Tadashi Kondo, Hiroaki Onaya, Takuji Okusaka ...Show all 19 authors... , Kazuaki Shimada, Yoshihiro Sakamoto, Minoru Esaki, Satoshi Nara, Tomoo Kosuge, Setsuo Hirohashi, Yae Kanai, Tatsuhiro Shibata; Show fewer authors
Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment.
Cancer Sci. 101:882-888(2010)

CLPUB00275
Sebastian Zach, Emrullah Birgin, Felix Ruckert;
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=26141945; DOI=10.1158/1535-7163.MCT-15-0069
Tomoki Shirota, Hidenori Ojima, Nobuyoshi Hiraoka, Kazuaki Shimada, Hirofumi Rokutan, Yasuhito Arai, Yae Kanai, Shinichi Miyagawa, Tatsuhiro Shibata;
Heat shock protein 90 is a potential therapeutic target in cholangiocarcinoma.
Mol. Cancer Ther. 14:1985-1993(2015)

PubMed=27833395; DOI=10.3748/wjg.v22.i40.9035; PMCID=PMC5083809
Hidenori Ojima, Seri Yamagishi, Kazuaki Shimada, Tatsuhiro Shibata;
Establishment of various biliary tract carcinoma cell lines and xenograft models for appropriate preclinical studies.
World J. Gastroenterol. 22:9035-9038(2016)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty ...Show all 17 authors... , Shannon Glaser, Lindsey Kennedy, Heather Francis, Wen-Jun Zhang, Gianfranco D. Alpini, Burcin Ekser; Show fewer authors
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)